Lapides Asset Management, LLC Trinity Biotech PLC Transaction History

Lapides Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$1.21 - $2.59 $793,155 - $1.7 Million	-655,500 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$1.57 - $3.02 $157 - $302	-100 Reduced 0.02%	655,500 $1.08 Million
Q1 2019 Apr 30, 2019	BUY	$2.31 - $3.22 $31,647 - $44,114	13,700 Added 2.13%	655,600 $1.87 Million
Q4 2018 Feb 13, 2019	SELL	$2.14 - $4.26 $1.13 Million - $2.26 Million	-530,200 Reduced 45.24%	641,900 $1.47 Million
Q3 2018 Oct 30, 2018	SELL	$3.76 - $5.08 $237,632 - $321,056	-63,200 Reduced 5.12%	1,172,100 $4.69 Million
Q2 2018 Jul 31, 2018	BUY	$4.46 - $5.2 $104,364 - $121,680	23,400 Added 1.93%	1,235,300 $6.18 Million
Q1 2018 May 01, 2018	BUY	$5.08 - $6.06 $195,580 - $233,309	38,500 Added 3.28%	1,211,900 $6.24 Million
Q4 2017 Feb 08, 2018	SELL	$4.5 - $5.77 $522,900 - $670,474	-116,200 Reduced 9.01%	1,173,400 $5.98 Million
Q3 2017 Nov 07, 2017	BUY	$5.16 - $5.67 $6.65 Million - $7.31 Million	1,289,600	1,289,600 $7.24 Million

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $44.6M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Lapides Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Lapides Asset Management, LLC with notifications on news.